Cáncer

ņQué tú puedes hacer para PREVENIRLO?   

1.    Elimina la carne de tu dieta, especialmente la carne roja o procesada.

2.    Come al menos 2½ tazas de vegetales y frutas al día.

3.    Escoge granos 100% integrales en vez de refinados. La fibra ayuda a combatir el cáncer.  Además ayudan a controlar el peso.

4.    No tomes más de 1 bebida alcohólica al día si eres mujer, 2 si eres hombre.

5.    Mantén un peso saludable. La grasa aumenta el riesgo de cáncer.

6.    Come orgánico.   La comida orgánica crece sin usar plaguicidas ni ser genéticamente modificada.  Varios estudios sugieren que los plaguicidas aumentan el riesgo a leucemia, linfomas, cáncer cerebral, cáncer del seno y de próstata y se ha encontrado más tumores en ratas alimentadas con maíz transgénico (GMO)

7.    Evita alimentos y aditivos artificiales y endulzantes artificiales; han sido asociados a cáncer de varios tipos. Evita (Equal, Splenda, etc) Usa azúcar negra, miel o Stevia  También evita el jarabe de maíz (corn syrup) el cual ha sido asociado a cáncer del páncreas según estudio en UCLA.

 

Además:

Š      Evita químicos en tu productos de higiene y en utensilios de cocina (plásticos) que han sido asociados a cáncer:

o   como esteroides sintéticos, Coteja en la lista “database” del Environmental Working Group (EWG) .

o   No importa que un molde diga “Microwave Safe”, eso solo significa que no se derrite, pero químicos se pueden infiltrar en tu comida, como BPA que es un irruptor hormonal, fthalatos, y antimonio.

o   Evita todo lo enlatado pues tiene mucho Bisphenol-A (BPA) por dentro.

Š      Sé físicamente activo.

Š      No fumes

Š      No uses desodorantes que sean anti-perspirantes con aluminio, algunos estudios indican posible relación. [http://terranaturals.com/pdf/mcgrath_full.pdf ]

Š      Evita todo los plásticos, muchos tienen phthalates, antimonio y BPA, los cuales se infiltran en tu comida, Esto incluye, agua embotellada. El BPA esta dentro de todos los productos enlatados y es un disruptor hormonal asociado a cáncer del seno, obesidad, impotencia y diabetes. http://www.medicalnewstoday.com/articles/221205.php

Š      Protege tu piel del sol con productos que no causen cáncer (ve EWG) y evita el sol entre 10am a 3pm

Š      Protégete de la radiación

 

 

ņSabías esto acerca de la carne?

Š      Consumption of meat is linked to an increased risk of colon cancer“-Harvard Medical School http://www.health.harvard.edu/ , http://www.cancerresearchuk.org/cancer-info/cancerstats/types/bowel/riskfactors/bowel-cancer-risk-factors

Š       “Red meat lovers have more kidney cancer” – National Institute of Health (NIH) http://www.nlm.nih.gov/

Š       Red meat linked to bowel cancer –UK Dept. of health http://www.dh.gov.uk/

Š      Red and processed meat consumption and risk of pancreatic cancer: meta-analysis of prospective studies” - British Journal of Cancer (2012) 106, 603–607. http://www.nature.com/bjc/journal/v106/n3/full/bjc2011585a.html

Š      Eating Red Meat Can Spur Cancer Progression” – Science Daily http://www.sciencedaily.com/releases/2008/11/081113181428.htm

 

 

Sources:

National Cancer Institute http://www.cancer.gov/cancertopics/factsheet/Risk/artificial-sweeteners

American Cancer Society http://www.cancer.org/

UN World Health Organization http://www.who.int/

American Institute for Cancer Research http://www.aicr.org/

The Cancer Project http://www.cancerproject.org/

Cancer Research UK, http://info.cancerresearchuk.org/

World Cancer Research Fund - www.wcrf-uk.org/

Pesticides and Cancer http://www.ncbi.nlm.nih.gov/pubmed/9498903

EPA http://www.epa.gov/pesticides/health/cancerfs.htm  

http://www.bbc.co.uk/news/health-22042995

 

Otros Enlaces Relacionados:
 Red meat chemical 'damages heart', say US scientists

Scientists Predict The World's Population Will Become Vegetarian By 2050 

Dr. R. A. Oppenlander explains why even Free-Range Organic Meat harms the Planet and your Health

 

*Un servicio de la iniciativa Colegial Campus Verde.  Una dieta anti-cáncer también favorece al planeta. Todos ganamos. http://campusverde.uprm.edu

Comparte esta información con tus seres amados.

Referencias

1.     Parkin DM, Boyd L, Walker LC. The fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010. Br J Cancer 2011;105(S2):S77-S81.

2.     Magalhaes B, Peleteiro B, Lunet N. Dietary patterns and colorectal cancer: systematic review and meta-analysis. Eur J Cancer Prev 2012;21(1):15-23.

3.     World Cancer Research Fund / American Institute for Cancer Research. Continuous Update Project: Colorectal Cancer Report 2010 Summary. Food, Nutrition, Physical Activity, and the Prevention of Colorectal Cancer. (PDF 1.11MB) 2011

4.     Chan DS, Lau R, Aune D, et al. Red and processed meat and colorectal cancer incidence: meta-analysis of prospective studies. PLoS One 2011;6(6):e20456.

5.     Sandhu MS, White IR, McPherson K. Systematic review of the prospective cohort studies on meat consumption and colorectal cancer risk: a meta-analytical approach. Cancer Epidemiol Biomarkers Prev 2001;10(5):439-46.

6.     Norat T, Lukanova A, Ferrari P, et al. Meat consumption and colorectal cancer risk: dose-response meta-analysis of epidemiological studies. Int J Cancer 2002;98(2):241-56.

7.     Larsson SC, Wolk A. Meat consumption and risk of colorectal cancer: a meta-analysis of prospective studies. Int J Cancer 2006;119(11):2657-64.

8.     Spencer EA, Key TJ, Appleby PN, et al. Meat, poultry and fish and risk of colorectal cancer: pooled analysis of data from the UK dietary cohort consortium. Cancer Causes Control 2010;21(9):1417-25.

9.     Parkin DM. 5. Cancers attributable to dietary factors in the UK in 2010. Br J Cancer 2011;105(s2):s24-S26.

10.  Geelen A, Schouten JM, Kamphuis C, et al. Fish consumption, n-3 fatty acids, and colorectal cancer: a meta-analysis of prospective cohort studies. Am J Epidemiol 2007;166(10):1116-25.

11.  Huxley RR, Ansary-Moghaddam A, Clifton P, et al. The impact of dietary and lifestyle risk factors on risk of colorectal cancer: a quantitative overview of the epidemiological evidence. Int J Cancer 2009;125(1):171-80.

12.  Sugawara Y, Kuriyama S, Kakizaki M, et al. Fish consumption and the risk of colorectal cancer: the Ohsaki Cohort Study. Br J Cancer 2009;101(5):849-54.

13.  Daniel CR, Cross AJ, Graubard BI, et al. Prospective investigation of poultry and fish intake in relation to cancer risk. Cancer Prev Res (Phila) 2011;4(11):1903-11.

14.  Aune D, Chan DS, Lau R, et al. Dietary fibre, whole grains, and risk of colorectal cancer: systematic review and dose-response meta-analysis of prospective studies. BMJ 2011;343:d6617.

15.  Parkin DM, Boyd L. 6. Cancers attributable to dietary factors in the UK in 2010. Br J Cancer 2011;105(S2):S27-S30.

16.  Aune D, Lau R, Chan DS, et al. Nonlinear reduction in risk for colorectal cancer by fruit and vegetable intake based on meta-analysis of prospective studies. Gastroenterology 2011;141(1):106-18.

17.  International Agency for Research on Cancer. Handbooks of Cancer Prevention: Fruit and Vegetables. Lyon, 2003.

18.  Kim JY, Kwon O. Garlic intake and cancer risk: an analysis using the Food and Drug Administration's evidence-based review system for the scientific evaluation of health claims. Am J Clin Nutr 2009;89(1):257-64.

19.  Ngo SN, Williams DB, Cobiac L, et al. Does garlic reduce risk of colorectal cancer? A systematic review. J Nutr 2007;137(10):2264-9.

20.  Fleischauer AT, Poole C, Arab L. Garlic consumption and cancer prevention: meta-analyses of colorectal and stomach cancers. Am J Clin Nutr 2000;72(4):1047-52.

21.  Liu L, Zhuang W, Wang RQ, et al. Is dietary fat associated with the risk of colorectal cancer? A meta-analysis of 13 prospective cohort studies. Eur J Nutr 2011;50(3):173-84.

22.  Aune D, Lau R, Chan DS, et al. Dairy products and colorectal cancer risk: a systematic review and meta-analysis of cohort studies. Ann Oncol 2012;23(1):37-45.

23.  Cho E, Smith-Warner SA, Spiegelman D, et al. Dairy foods, calcium, and colorectal cancer: a pooled analysis of 10 cohort studies. J Natl Cancer Inst 2004;96(13):1015-22.

24.  Pala V, Sieri S, Berrino F, et al. Yogurt consumption and risk of colorectal cancer in the Italian European prospective investigation into cancer and nutrition cohort. Int J Cancer 2011;129(11):2712-9.

25.  Gnagnarella P, Gandini S, La Vecchia C, et al. Glycemic index, glycemic load, and cancer risk: a meta-analysis. Am J Clin Nutr 2008;87(6):1793-801.

26.  Mulholland HG, Murray LJ, Cardwell CR, et al. Glycemic index, glycemic load, and risk of digestive tract neoplasms: a systematic review and meta-analysis. Am J Clin Nutr 2009;89(2):568-76.

27.  Zhang X, Albanes D, Beeson WL, et al. Risk of colon cancer and coffee, tea, and sugar-sweetened soft drink intake: pooled analysis of prospective cohort studies . J Natl Cancer Inst 2010;102(11):771-83.

28.  Kennedy DA, Stern SJ, Moretti M, et al. Folate intake and the risk of colorectal cancer: a systematic review and meta-analysis. Cancer Epidemiol 2011;35(1):2-10.

29.  Cooper K, Squires H, Carroll C, et al. Chemoprevention of colorectal cancer: systematic review and economic evaluation. Health Technol Assess 2010;14(32):1-206.

30.  Sanjoaquin MA, Allen N, Couto E, et al. Folate intake and colorectal cancer risk: a meta-analytical approach. Int J Cancer 2005;113(5):825-8.

31.  Fife J, Raniga S, Hider PN, et al. Folic acid supplementation and colorectal cancer risk: a meta-analysis. Colorectal Dis 2009;13(2):132-7.

32.  Van Guelpen B, Hultdin J, Johansson I, et al. Low folate levels may protect against colorectal cancer. Gut 2006;55(10):1461-6.

33.  Hubner RA and Houlston RS. olate and colorectal cancer prevention. Br J Cancer 2009;100(2):233-9.

34.  Lee JE, Willett WC, Fuchs CS, et al. Folate intake and risk of colorectal cancer and adenoma: modification by time. Am J Clin Nutr 2011;93(4):817-25.

35.  Gibson TM, Weinstein SJ, Pfeiffer RM, et al. Pre- and postfortification intake of folate and risk of colorectal cancer in a large prospective cohort study in the United States, Am J Clin Nutr 2011;94(4):1053-62.

36.  Takata Y, Kristal AR, King IB, et al. Serum selenium, genetic variation in selenoenzymes, and risk of colorectal cancer: primary analysis from the Women's Health Initiative Observational Study and meta-analysis. Cancer Epidemiol Biomarkers Prev 2011;20(9):1822-30.

37.  Jacobs ET, Jiang R, Alberts DS, et al. Selenium and colorectal adenoma: results of a pooled analysis. J Natl Cancer Inst 2004;96(22):1669-75.

38.  Dennert G, Zwahlen M, Brinkman M, et al. Selenium for preventing cancer. Cochrane Database Syst Rev 2011(5):CD005195.

39.  Papaioannou D, Cooper KL, Carroll C, et al. Antioxidants in the chemoprevention of colorectal cancer and colorectal adenomas in the general population: a systematic review and meta-analysis. Colorectal Dis 2011;13(10):1085-99.

40.  Larsson SC, Orsini N, Wolk A. Vitamin B6 and risk of colorectal cancer: a meta-analysis of prospective studies. JAMA 2010;303(11):1077-83.

41.  Chan AT, Giovannucci EL. Primary prevention of colorectal cancer. Gastroenterology 2010;138(6):2029-43 e10.

42.  Eussen SJ, Vollset SE, Hustad S, et al. Plasma vitamins B2, B6, and B12, and related genetic variants as predictors of colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 2010;19(10):2549-61.

43.  Key TJ, Appleby PN, Masset G, et al. Vitamins, minerals, essential fatty acids and colorectal cancer risk in the United Kingdom dietary cohort consortium. Int J Cancer 2011.

44.  Le Marchand L, Wang H, Selhub J, et al. Association of plasma vitamin B6 with risk of colorectal adenoma in a multiethnic case-control study. Cancer Causes Control 2011;22(6):929-36.

45.  Kune G, Watson L. Lowering the Risk of Rectal Cancer among Habitual Beer Drinkers by Dietary Means. Adv Prev Med 2011;2011:874048.

46.  Dahlin AM, Van Guelpen B, Hultdin J, et al. Plasma vitamin B12 concentrations and the risk of colorectal cancer: a nested case-referent study. Int J Cancer 2008;122(9):2057-61.

47.  Carroll C, Cooper K, Papaioannou D, Hind D, Pilgrim H, Tappenden P. Supplemental calcium in the chemoprevention of colorectal cancer: a systematic review and meta-analysis. Clin Ther 2010;32(5):789-803.

48.  Weingarten MA, Zalmanovici A, Yaphe J. Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps. Cochrane Database Syst Rev 2008(1):CD003548.

49.  Wactawski-Wende J, Kotchen JM, Anderson GL, et al. Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med 2006;354(7):684-96.

50.  Ma Y, Zhang P, Wang F, et al. Association between vitamin D and risk of colorectal cancer: a systematic review of prospective studies. J Clin Oncol 2011;29(28):3775-82.

51.  Yin L, Grandi N, Raum E, et al. Meta-analysis: Serum vitamin D and colorectal adenoma risk. Prev Med 2011;53(1-2):10-6.

52.  Gandini S, Boniol M, Haukka J, et al. Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma. Int J Cancer 2011;128(6):1414-24.

53.  Key TJ, Allen NE, Spencer EA, et al. The effect of diet on risk of cancer. Lancet 2002;360(9336):861-8.

54.  Department of Environment Food and Rural Affairs. UK household purchased quantities of food and drink (National Food Survey, Expenditure and Food Survey Living Costs and Food Survey) (PDF 304KB) 2011.

55.  The NHS Information Centre for Health and Social Care. Health Survey for England - 2009 trend tables. 2010.

56.  Department of Health/Food Standards Agency. National Diet and Nutrition Survey: Headline results from Years 1 and 2 (combined) of the Rolling Programme (2008/2009 - 2009/10). 2011.

57.  Harriss DJ, Atkinson G, George K, et al. Lifestyle factors and colorectal cancer risk (1): systematic review and meta-analysis of associations with body mass index. Colorectal Dis 2009;11(6):547-63.

58.  Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008;371(9612):569-78.

59.  Larsson SC, Wolk A. Obesity and colon and rectal cancer risk: a meta-analysis of prospective studies. Am J Clin Nutr 2007;86(3):556-65.

60.  Moghaddam AA, Woodward M, Huxley R. Obesity and risk of colorectal cancer: a meta-analysis of 31 studies with 70,000 events. Epidemiol Biomarkers Prev 2007;16(12):2533-47.

61.  Terry P, Giovannucci E, Bergkvist L, et al. Body weight and colorectal cancer risk in a cohort of Swedish women: relation varies by age and cancer site. Br J Cancer 2001;85(3):346-9.

62.  Slattery ML, Ballard-Barbash R, Edwards S, et. Body mass index and colon cancer: an evaluation of the modifying effects of estrogen (United States). Cancer Causes Control 2003;14(1):75-84.

63.  Hoffmeister M, Raum E, Winter J, et al. Hormone replacement therapy, body mass, and the risk of colorectal cancer among postmenopausal women from Germany. Br J Cancer 2007;97(11):1486-92.

64.  Pischon T, Lahmann PH, Boeing H, et al. Body size and risk of colon and rectal cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC). J Natl Cancer Inst 2006;98(13):920-31.

65.  Parkin DM, Boyd L. Cancers attributable to overweight and obesity in the UK in 2010. Br J Cancer 2011;105 Suppl 2:S34-7.

66.  Harriss DJ, Atkinson G, Batterham A, et al. Lifestyle factors and colorectal cancer risk (2): a systematic review and meta-analysis of associations with leisure-time physical activity. Colorectal Dis 2009;11(7):689-701.

67.  Wolin KY, Yan Y, Colditz GA, et al. Physical activity and colon cancer prevention: a meta-analysis. Br J Cancer 2009;100(4):611-6

68.  Wolin KY, Yan Y, Colditz GA. Physical activity and risk of colon adenoma: a meta-analysis. Br J Cancer 2011;104(5):882-5.

69.  Parkin DM. Cancers attributable to inadequate physical exercise in the UK in 2010. Br J Cancer 2011;105(S2):S38-S41.

70.  Fedirko V, Tramacere I, Bagnardi V, et al. Alcohol drinking and colorectal cancer risk: an overall and dose-response meta-analysis of published studies. Ann Oncol 2011;22(9):1958-72.

71.  Parkin DM. Cancers attributable to consumption of alcohol in the UK in 2010. Br J Cancer 2011;105(S2):S14-S18.

72.  Tsoi KK, Pau CY, Wu WK, et al. Cigarette smoking and the risk of colorectal cancer: a meta-analysis of prospective cohort studies. Clin Gastroenterol Hepatol 2009;7(6):682-88 e1-5.

73.  Botteri E, Iodice S, Bagnardi V, et al. Smoking and colorectal cancer: a meta-analysis. JAMA 2008;300(23):2765-78.

74.  Liang PS, Chen TY, Giovannucci E. Cigarette smoking and colorectal cancer incidence and mortality: systematic review and meta-analysis. Int J Cancer 2009;124(10):2406-15.

75.  Botteri E, Iodice S, Raimondi S, et al. Cigarette smoking and adenomatous polyps: a meta-analysis. Gastroenterology 2008;134(2):388-95.

76.  Parkin DM. Tobacco-attributable cancer burden in the UK in 2010. BJC 2011;105 Suppl 2:S6-S13.

77.  Rothwell PM, Wilson M, Elwin CE, et al. Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. Lancet 2010;376(9754):1741-50.

78.  Rothwell PM, Fowkes FGR, Belch JFF, et al. Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials. Lancet 2011;377(9759):31-41.

79.  Ricchi P, Zarrilli R, Di Palma A, et al. Nonsteroidal anti-inflammatory drugs in colorectal cancer: from prevention to therapy. Br J Cancer 2003;88(6):803-7.

80.  Baron JA, Cole BF, Sandler RS, et al. A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med 2003;348(10):891-9.

81.  Sandler RS, Halabi S, Baron JA, et al. A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. N Engl J Med 2003;348(10):883-90.

82.  Bonovas S, Filioussi K, Flordellis CS, et al. Statins and the risk of colorectal cancer: a meta-analysis of 18 studies involving more than 1.5 million patients. J Clin Oncol 2007;25(23):3462-8.

83.  Boudreau DM, Yu O, Johnson J. Statin use and cancer risk: a comprehensive review. Expert Opin Drug Saf 2010;9(4):603-21.

84.  Browning DR, Martin RM. Statins and risk of cancer: a systematic review and metaanalysis. Int J Cancer 2007;120(4):833-43.

85.  Simon MS, Rosenberg CA, Rodabough RJ, et al. Prospective analysis of association between use of statins or other lipid-lowering agents and colorectal cancer risk. Ann Epidemiol 2012;22(1):17-27.

86.  Vinogradova Y, Coupland C, Hippisley-Cox J. Exposure to statins and risk of common cancers: a series of nested case-control studies. BMC Cancer 2011;11:409.

87.  Grodstein F, Newcomb PA, Stampfer MJ. Postmenopausal hormone therapy and the risk of colorectal cancer: a review and meta-analysis. The American Journal of Medicine 1999;106(5):574-82.

88.  Hebert-Croteau N. A meta-analysis of hormone replacement therapy and colon cancer in women. Cancer Epidemiol Biomarkers Prev 1998;7(8):653-9.

89.  Nanda K, Bastian LA, Hasselblad V, et al. Hormone replacement therapy and the risk of colorectal cancer: a meta-analysis. Obstet Gynecol 1999;93(5 Pt 2):880-8.

90.  Tsilidis KK, Allen NE, Key TJ, et al. Menopausal hormone therapy and risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 2011;128(8):1881-9.

91.  Anderson GL, Limacher M, Assaf AR, et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 2004;291(14):1701-12.

92.  Csizmadi I, Collet JP, Benedetti A, et al. The effects of transdermal and oral oestrogen replacement therapy on colorectal cancer risk in postmenopausal women. Br J Cancer 2004;90(1):76-81.

93.  Hildebrand JS, Jacobs EJ, Campbell PT, et al. Colorectal cancer incidence and postmenopausal hormone use by type, recency, and duration in cancer prevention study II. Cancer Epidemiol Biomarkers Prev 2009;18(11):2835-41.

94.  Hulley S, Furberg C, Barrett-Connor E, et al. Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA 2002;288(1):58-66.

95.  Chlebowski RT, Wactawski-Wende J, Ritenbaugh C, et al. Estrogen plus progestin and colorectal cancer in postmenopausal women. N Engl J Med 2004;350(10):991-1004.

96.  Bosetti C, Bravi F, Negri E, et al. Oral contraceptives and colorectal cancer risk: a systematic review and meta-analysis. Hum Reprod Update 2009;15(5):489-98.

97.  Tsilidis KK, Allen NE, Key TJ, et al. Oral contraceptives, reproductive history and risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition. Br J Cancer 2010;103(11):1755-9.

98.  Long MD, Martin CF, Galanko JA, et al. Hormone replacement therapy, oral contraceptive use, and distal large bowel cancer: a population-based case-control study. Am J Gastroenterol 2010;105(8):1843-50.

99.  Potter JD, Hunter DI. Colorectal Cancer. In: Adami HO, Hunter D, Trichopoulos D, editors. Textbook of cancer epidemiology. New York: Oxford University Press, 2002:188-211.

100.     Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001;48(4):526-35.

101.     Laukoetter MG, Mennigen R, Hannig CM, et al. Intestinal cancer risk in Crohn's disease: a meta-analysis. J Gastrointest Surg 2011;15(4):576-83.

102.     Canavan C, Abrams KR, Mayberry J. Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn's disease. Aliment Pharmacol Ther 2006;23(8):1097-104.

103.     Jiang Y, Ben Q, Shen H, et al. Diabetes mellitus and incidence and mortality of colorectal cancer: a systematic review and meta-analysis of cohort studies. Eur J Epidemiol 2011;26(11):863-76.

104.     Kramer HU, Schottker B, Raum E, et al. Type 2 diabetes mellitus and colorectal cancer: Meta-analysis on sex-specific differences. Eur J Cancer 2011.

105.     Larsson SC, Orsini N, Wolk A. Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst 2005;97(22):1679-87.

106.     Luo W, Cao Y, Liao C, et al. Diabetes mellitus and the incidence and mortality of colorectal cancer: A meta-analysis of twenty four cohort studies. Colorectal Dis 2011.

107.     Shao T, Yang YX. Cholecystectomy and the risk of colorectal cancer. Am J Gastroenterol 2005;100(8):1813-20.

108.     Schernhammer ES, Leitzmann MF, Michaud DS, et al. Cholecystectomy and the risk for developing colorectal cancer and distal colorectal adenomas. Br J Cancer 2003;88(1):79-83.

109.     Lagergren J, Ye W, Ekbom A. Intestinal cancer after cholecystectomy: is bile involved in carcinogenesis? Gastroenterology 2001;121(3):542-7.

110.     Goldacre MJ, Abisgold JD, Seagroatt V, et al. Cancer after cholecystectomy: record-linkage cohort study. Br J Cancer 2005;92(7):1307-9.

111.     Vinikoor LC, Galanko JA, Sandler RS. Cholecystectomy and the risk of colorectal adenomas. Dig Dis Sci 2008;53(3):730-5.

112.     Hoots BE, Palefsky JM, Pimenta JM, et al. Human papillomavirus type distribution in anal cancer and anal intraepithelial lesions. Int J Cancer 2009;124(10):2375-83.

113.     Parkin DM. Cancers attributable to infection in the UK in 2010. Br J Cancer 2011;105 Suppl 2:S49-56.

114.     Parkin DM, Darby SC.Cancers in 2010 attributable to ionising radiation exposure in the UK. Br J Cancer 2011;105 Suppl 2:S57-65.

115.     Fearnhead NS, Wilding JL, Bodmer WF. Genetics of colorectal cancer: hereditary aspects and overview of colorectal tumorigenesis. Brit Med Bull 2002;64(1):27-43.

116.     Galiatsatos P, Foulkes WD. Familial adenomatous polyposis. Am J Gastroenterol 2006;101(2):385-98.

117.     Gala M, Chung DC. Hereditary colon cancer syndromes. Semin Oncol 2011;38(4):490-9.

118.     Dunlop MG, Farrington SM, Carothers AD, et al. Cancer risk associated with germline DNA mismatch repair gene mutations. Hum Mol Genet 1997;6(1):105-10.

119.     Johns LE, Houlston RS. A systematic review and meta-analysis of familial colorectal cancer risk. Am J Gastroenterol 2001;96(10):2992-3003.

120.     Butterworth AS, Higgins JP, Pharoah P. Relative and absolute risk of colorectal cancer for individuals with a family history: a meta-analysis. Eur J Cancer 2006;42(2):216-27.

121.     Wilschut JA, Habbema JD, Ramsey SD, et al. Increased risk of adenomas in individuals with a family history of colorectal cancer: results of a meta-analysis. Cancer Causes Control 2010;21(12):2287-93.

122.     Secretan B, Straif K, Baan R, et al. A review of human carcinogens-Part E: tobacco, areca nut, alcohol, coal smoke, and salted fish. Lancet Oncol 2009;10(11):1033-4.

123.     Soranna D, Scotti L, Zambon A, et al. Cancer risk associated with use of metformin and sulfonylurea in type 2 diabetes: a meta-analysis. Oncologist. 2012;17(6):813-22.

124.     Chiong C, Cox MR, Eslick GD. Gallstones Are Associated with Colonic Adenoma: A Meta-analysis. World J Surg. 2012.

125.     Chiong C, Cox MR, Eslick GD. Gallstone disease is associated with rectal cancer: a meta-analysis. Scand J Gastroenterol. 2012;47(5):553-64.

126.     Algra AM, Rothwell PM. Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials. Lancet Oncol. 2012;13(5):518-27.

127.     Wu S, Feng B, Li K, et al. Fish consumption and colorectal cancer risk in humans: a systematic review and meta-analysis. Am J Med. 2012;125(6):551-9.

128.     Tuohy TMF, Rowe KG, Mineau GP, et al. Risk of Colorectal Cancer and Adenomas in the Families of Patients With Adenomas. Cancer. 2013 Oct 21.

129.     Li P, Xu J, Shi Y, et al. Association between zinc intake and risk of digestive tract cancers: A systematic review and meta-analysis. Clin Nutr. 2013 Oct 10.

130.     Sharma PV, Eglinton T, Hider P. Systematic Review and Meta-analysis of the Role of Routine Colonic Evaluation After Radiologically Confirmed Acute Diverticulitis. Ann Surg. 2013 Oct 28.

131.     Singh S, Singh H, Singh PP, et al. Antidiabetic Medications and the Risk of Colorectal Cancer in Patients with Diabetes Mellitus: A Systematic Review and Meta-analysis. Cancer Epidemiol Biomarkers Prev. 2013 Nov 12.

132.     Wang L, Cai S, Teng Z. Insulin therapy contributes to the increased risk of colorectal cancer in diabetes patients: a meta-analysis. Diagn Pathol. 2013 Oct 31;8(1):180.

133.     Sun A, Liu R, Sun G. Insulin therapy and risk of colorectal cancer: an updated meta-analysis of epidemiological studies. Curr Med Res Opin. 2013 Nov 6.

134.     Wu L, Yu C, Jiang H, et al. Diabetes mellitus and the occurrence of colorectal cancer: an updated meta-analysis of cohort studies. Diabetes Technol Ther. 2013 May;15(5):419-27.

135.     Damin DC, Ziegelmann PK, Damin AP. Human papillomavirus infection and colorectal cancer risk: a meta-analysis. Colorectal Dis. 2013 Aug;15(8):e420-8.

136.     Wu Q, Yang ZP, Xu P, et al. Association between Helicobacter pylori infection and the risk of colorectal neoplasia: a systematic review and meta-analysis. Colorectal Dis. 2013 Jul;15(7):e352-64.

137.     Rokkas T, Sechopoulos P, Pistiolas D, et al. The relationship of Helicobacter pylori infection and colon neoplasia, on the basis of meta-analysis. Eur J Gastroenterol Hepatol. 2013 Nov;25(11):1286-94.

138.     Grulich AE, van Leeuwen MT, Falster MO, et al. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet. 2007 Jul 7;370(9581):59-67.

139.     Shiels MS, Cole SR, Kirk GD, et al. A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals. J Acquir Immune Defic Syndr. 2009 Dec;52(5):611-22.

140.     Keller SC, Momplaisir F, Lo Re V, et al. Colorectal cancer incidence and screening in US Medicaid patients with and without HIV infection. AIDS Care. 2013 Nov 5.

141.     Jacobs ET, Hibler EA, Lance P, et al. Association between circulating concentrations of 25(OH)D and colorectal adenoma: a pooled analysis. Int J Cancer. 2013 Dec 15;133(12):2980-8.

142.     Ananthakrishnan AN, Cheng SC, Cai T, et al. Association Between Reduced Plasma 25-hydroxy Vitamin D and Increased Risk of Cancer in Patients with Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol. 2013 Oct 23. pii: S1542-3565(13)01644-3.

143.     Wiren S, Haggstrom C, Ulmer H, et al. Pooled cohort study on height and risk of cancer and cancer death. Cancer Causes Control. 2013 Oct 31.

144.     Wei EK, Giovannucci E, Wu K, et al. Comparison of risk factors for colon and rectal cancer. Int J Cancer. 2004 Jan 20;108(3):433-42.

145.     Ben Q, Sun Y, Chai R, et al. Dietary Fiber Intake Reduces Risk for Colorectal Adenoma: a Meta-Analysis. Gastroenterology. 2013 Nov 8. pii: S0016-5085(13)01586-2.

146.     Robsahm TE, Aagnes B, Hjartaker A, et al. Body mass index, physical activity, and colorectal cancer by anatomical subsites: a systematic review and meta-analysis of cohort studies. Eur J Cancer Prev. 2013 Nov;22(6):492-505.

147.     Boyle T, Keegel T, Bull F, et al. Physical activity and risks of proximal and distal colon cancers: a systematic review and meta-analysis. J Natl Cancer Inst. 2012 Oct 17;104(20):1548-61.

148.     Cong YJ, Gan Y, Sun HL, et al. Association of sedentary behaviour with colon and rectal cancer: a meta-analysis of observational studies. Br J Cancer. 2013 Nov 21.

149.     Fonseca-Nunes A, Jakszyn P, Agudo A. Iron and Cancer Risk - A systematic review and meta-analysis of the epidemiological evidence. Cancer Epidemiol Biomarkers Prev. 2013 Nov 15.